BAC
Bank of America Corporation
BAC has a slight edge over TCBX overall, supported by stronger fundamentals and stronger modeled upside.
TCBX
Third Coast Bancshares, Inc.
TCBX trails on the overall score without a compensating advantage in the available component scores.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
TCBX Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
TCBX's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like TCBX.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
TCBX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 9.7x | $39.68 | — |
| Cheap | 9.9x | $38.58 | -2.8% |
| Current | 10x | $39.68 | — |
| Fair | 11x | $41.75 | +5.2% |
| Expensive | 12x | $47.55 | +20% |
Historical ranges are pointers, not guarantees.
TCBX has the edge over BAC in the historical PE scenario, which offers more potential upside but is not a forecast.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over TCBX on the outlook, with more favorable valuation and profitability expectations.
TCBX Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for TCBX, but weaker profitability.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.
TCBX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.09 | +4.6% |
| Q3 2026 | $3.91 | +9.5% |
| Q2 2026 | $4.01 | +22% |
| Q1 2026 | $3.89 | +32% |
| Q4 2025 | $3.79 | +36% |
| Q3 2025 | $3.57 | +39% |
| Q2 2025 | $3.28 | +53% |
| Q1 2025 | $2.95 | +45% |
| Q4 2024 | $2.78 | +40% |
TCBX has the edge over BAC on earnings, with stronger typical year-over-year growth.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
TCBX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $65.9M | +21% |
| Q2 2026 | $68M | +31% |
| Q1 2026 | $57.7M | +26% |
| Q4 2025 | $56.5M | +22% |
| Q3 2025 | $54.5M | +27% |
| Q2 2025 | $52M | +25% |
| Q1 2025 | $45.9M | +14% |
| Q4 2024 | $46.3M | +17% |
TCBX has the edge over BAC on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 36% | -5.8 points |
| Q2 2026 | 40% | 0 points |
| Q1 2026 | 33% | -4.9 points |
| Q4 2025 | 38% | -0.6 points |
| Q3 2025 | 42% | +4 points |
| Q2 2025 | 40% | +6.4 points |
| Q1 2025 | 38% | +5.8 points |
| Q4 2024 | 39% | +8.4 points |
TCBX has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
TCBX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.9M | -57% |
| Q2 2026 | $45M | +224% |
| Q1 2026 | -$38.7M | -469% |
| Q3 2025 | $20.7M | -5.8% |
| Q2 2025 | $13.9M | +90% |
| Q1 2025 | $10.5M | +11% |
| Q3 2024 | $22M | +1077% |
| Q2 2024 | $7.3M | -22% |
TCBX's free cash flow was $21M over the past year, down 69% from the year before. Free cash flow isn't a meaningful measure for financial services companies like TCBX.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over TCBX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
TCBX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +101K shares |
| 1 year | +18% | +3M shares |
| 3 years | +21% | +3.6M shares |
TCBX has 20M diluted shares, up 18% from a year ago.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
TCBX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -3.0x | Net Cash |
| Q2 2026 | -3.6x | Net Cash |
| Q1 2026 | -4.1x | Net Cash |
| Q4 2025 | -1.6x | Net Cash |
| Q3 2025 | -0.9x | Net Cash |
| Q2 2025 | -1.0x | Net Cash |
| Q1 2025 | -2.5x | Net Cash |
| Q4 2024 | -4.9x | Net Cash |
TCBX has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
TCBX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.3 | Neutral |
| Stochastic | 7.5 | Oversold |
TCBX's weekly RSI is 43 (neutral) and its Stochastic is 8 (oversold).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
TCBX PE vs Financial Services Sector
| Metric | TCBX | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 13x | 22% below |
| PE % | 26 | 64 | 38 pts below |
TCBX has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
TCBX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $40.9 | 3.1% below |
| 20 week MA | $42.6 | 6.7% below |
| 50 week MA | $40.6 | 2.3% below |
| 100 week MA | $37.7 | 5.2% above |
| 200 week MA | $29.1 | 36% above |
TCBX has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
TCBX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $25.1 | $25.9 | +3.3% |
| 2022 | $25.9 | $18.5 | -28% |
| 2023 | $18.5 | $19.9 | +7.2% |
| 2024 | $19.9 | $34.1 | +72% |
| 2025 | $34.1 | $39.4 | +15% |
| 2026 YTD | $39.4 | $39.7 | +0.7% |
TCBX has the edge over BAC on returns for 2026, with the stronger performance.